Bris­tol My­ers scores ac­cel­er­at­ed ap­proval in more blood can­cers for CAR-T ther­a­py Breyanzi

Bris­tol My­ers Squibb is bring­ing its CAR-T cell ther­a­py to adults with re­lapsed or re­frac­to­ry chron­ic lym­pho­cyt­ic leukemia or small lym­pho­cyt­ic lym­phoma, thanks to an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.